| 1 |
32328672 | Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model. | 2020 Sep |
1 |
| 2 |
32333917 | The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies. | 2020 Jul 1 |
1 |
| 3 |
32551517 | Codelivered Chemotherapeutic Doxorubicin via a Dual-Functional Immunostimulatory Polymeric Prodrug for Breast Cancer Immunochemotherapy. | 2020 Jul 15 |
1 |
| 4 |
32763819 | Temporary blockade of interferon-γ ameliorates doxorubicin-induced cardiotoxicity without influencing the anti-tumor effect. | 2020 Oct |
9 |
| 5 |
30426505 | Doxorubicin-induced cardiotoxicity involves IFNγ-mediated metabolic reprogramming in cardiomyocytes. | 2019 Mar |
12 |
| 6 |
30930305 | Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy. | 2019 May |
1 |
| 7 |
31744501 | Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators. | 2019 Nov 19 |
1 |
| 8 |
29391351 | T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors. | 2018 Jun 15 |
2 |
| 9 |
29744449 | DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment. | 2018 Mar |
1 |
| 10 |
30011369 | Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy. | 2018 Sep 4 |
1 |
| 11 |
28457491 | Chemoimmunotherapeutic effect of combined treatment with ex vivo generated antigen-presenting immune cells and conventional antitumor agents in a mouse neuroblastoma model. | 2017 Oct |
1 |
| 12 |
27576789 | Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice. | 2016 Aug 31 |
1 |
| 13 |
24197130 | Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. | 2014 Jan 1 |
1 |
| 14 |
24520271 | Doxorubicin treatment induces tumor cell death followed by immunomodulation in a murine neuroblastoma model. | 2014 Mar |
2 |
| 15 |
23637542 | Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment. | 2013 |
1 |
| 16 |
23843024 | Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response. | 2013 Oct |
1 |
| 17 |
21512265 | Oral administration of immunopotentiator from Pantoea agglomerans 1 (IP-PA1) improves the survival of B16 melanoma-inoculated model mice. | 2011 |
1 |
| 18 |
21646474 | Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. | 2011 Jul 15 |
1 |
| 19 |
21920376 | p21(WAF1/Cip1/Sdi1) knockout mice respond to doxorubicin with reduced cardiotoxicity. | 2011 Nov 15 |
1 |
| 20 |
18062793 | Lipopolysaccharide augments the in vivo lethal action of doxorubicin against mice via hepatic damage. | 2008 Feb |
3 |
| 21 |
17634555 | Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect. | 2007 Jul 15 |
10 |
| 22 |
16857809 | Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis. | 2006 Jul 15 |
1 |
| 23 |
15914329 | Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism. | 2005 Jul |
1 |
| 24 |
16102261 | Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice. | 2005 Aug |
1 |
| 25 |
15466213 | Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin. | 2004 Oct 1 |
7 |
| 26 |
12698271 | Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells. | 2003 Jul |
5 |
| 27 |
9688305 | Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin. | 1998 Aug 31 |
1 |
| 28 |
2120134 | Induction of macrophage procoagulant expression by cisplatin, daunorubicin and doxorubicin. | 1990 Oct 15 |
1 |